The morbidly obese members of the so-called National Association to Advance Fat Acceptance (NAAFA) have predictably come out ...

Jillian Michaels was a coach alongside Bob Harber on 'The Biggest Loser' in 2004 and has continued talking about fitness, ...

The Apprentice star, 56, shared a glam snap as she posed in a chic white dress, displaying a slimmer frame and tauter visage.

Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...

Twelve percent of adults in the United States have taken them at some point, according to a 2024 KFF Health Tracking Poll, ...

Christina Aguilera is shocking fans with her visible chest bones in a braless dress as she sparks even more Ozempic rumors.

During a weeklong joint operation between U.S. Customs and Border Protection and U.S. Food and Drug Administration, CBP officers inspected hundreds of boxes containing possible counterfeit and ...

A state-licensed pharmacy in Washington, Iowa that has been sued by business partners for millions of dollars is now being ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...